Alexander Lachmann | Mount Sinai

Biography

Research Topics

Bioinformatics, Biomedical Informatics, Biomedical Sciences, Biostatistics, Computational Biology, Drug Design and Discovery, Gene Regulation, Genomics

Education

Diplom, University Aachen

PhD, Columbia University

Publications

50

Publications

Selected Publications

Playbook workflow builder: Interactive construction of bioinformatics workflows. Daniel J.B. Clarke, John Erol Evangelista, Zhuorui Xie, Giacomo B. Marino, Anna I. Byrd, Mano R. Maurya, Sumana Srinivasan, Keyang Yu, Varduhi Petrosyan, Matthew E. Roth, Miroslav Milinkov, Charles Hadley King, Jeet Kiran Vora, Jonathon Keeney, Christopher Nemarich, William Khan, Alexander Lachmann, Nasheath Ahmed, Alexandra Agris, Juncheng Pan, Srinivasan Ramachandran, Eoin Fahy, Emmanuel Esquivel, Aleksandar Mihajlovic, Bosko Jevtic, Vuk Milinovic, Sean Kim, Patrick McNeely, Tianyi Wang, Eric Wenger, Miguel A. Brown, Alexander Sickler, Yuankun Zhu, Sherry L. Jenkins, Philip D. Blood, Deanne M. Taylor, Adam C. Resnick, Raja Mazumder, Aleksandar Milosavljevic, Shankar Subramaniam, Avi Ma’ayan. PLoS Computational Biology

RummaGEO: Automatic mining of human and mouse gene sets from GEO. Giacomo B. Marino, Daniel J.B. Clarke, Alexander Lachmann, Eden Z. Deng, Avi Ma'ayan. Patterns

PrismEXP: gene annotation prediction from stratified gene-gene co-expression matrices. Alexander Lachmann, Kaeli A. Rizzo, Alon Bartal, Minji Jeon, Daniel J.B. Clarke, Avi Ma’ayan. PeerJ

View All Publications

Office Locations

Annenberg Building Floor 19 Room 19-60C

1468 Madison Ave

New York, NY 10029

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Lachmann during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Lachmann during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.